Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Completed 4Withdrawn 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Urogenital Neoplasms 4Prostatic Neoplasms 4Prostatic Diseases 4Neoplasms by Site 4Neoplasms 4Male Urogenital Diseases 4Genital Neoplasms, Male 4Carcinoma 4Genital Diseases, Male 3Genital Diseases 1

Interventions

padeliporfin 4motexafin gadolinium 2Sunitinib 2Radiotherapy 2Paclitaxel 2Genetic Testing 2Carboplatin 2vinflunine 1temsirolimus 1sipuleucel-T 1niraparib 1luprolide acetate gel depot 1apalutamide 1Tinzaparin 1Therapeutics 1Taste 1Surveys and Questionnaires 1Specimen Handling 1Sildenafil Citrate 1Remote Patient Monitoring 1Radiation Dose Hypofractionation 1Pemetrexed 1Ocoxin 1Neoadjuvant Therapy 1Leuprolide 1Immunotherapy 1Imatinib Mesylate 1Imagery, Psychotherapy 1Genetic Counseling 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Urogenital Neoplasms × padeliporfin × Clear all
NCT01310894 2019-07-11

PCM301

Steba Biotech S.A.

Phase 3 Completed
413 enrolled
Genitourinary

Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT00707356 2016-04-19

Study of WST11 in Patients With Localized Prostate Cancer

Steba Biotech S.A.

Phase 2 Completed
42 enrolled
Genitourinary

Genital Diseases, Carcinoma, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT01875393 2016-04-19

PCM304

Steba Biotech S.A.

Phase 3 Completed
81 enrolled
Genitourinary

Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT00975429 2015-04-28

Study Using WST11 in Patients With Localized Prostate Cancer

Steba Biotech S.A.

Phase 2 Completed
86 enrolled
Genitourinary

Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡